Erratum to: Kerr KM. The PD-L1 immunohistochemistry biomarker: two steps forward, one step back? J Thorac Oncol. 2018;13(3):291-294

Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 13(8)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9649811f8175744df13a9663769da265
https://pubmed.ncbi.nlm.nih.gov/29472051

Differentiating Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases With Emphasis on Pathological and Molecular Considerations: Recommendations From the International Association for the Study of Lung Cancer Pathology Committee.

Autor: Chou TY; Department of Pathology and Precision Medicine Research Center, Taipei Medical University Hospital and Graduate Institute of Clinical Medicine, School of Medicine and Precision Health Center, Taipei Medical University, Taipei, Taiwan. Electronic address: tehying@tmu.edu.tw., Dacic S; Department of Pathology, Yale School of Medicine, New Haven, Connecticut., Wistuba I; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Beasley MB; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York., Berezowska S; Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Chang YC; Department of Medical Imaging, National Taiwan University Hospital, Taipei, Taiwan., Chung JH; Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea., Connolly C; International Association for the Study of Lung Cancer, Denver, Colorado., Han Y; Department of Pathology, Shanghai Chest Hospital, Jiaotong University, Shanghai, People's Republic of China., Hirsch FR; Center for Thoracic Oncology, The Tisch Cancer Institute, New York, New York and Icahn School of Medicine, Mount Sinai Health System, New York, New York., Hwang DM; Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Odette Cancer Centre, Ontario, Canada., Janowczyk A; Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, Georgia., Joubert P; Institut Universitaire de Cardiologie et de Pneumologie de Quebec - Université Laval, Quebec City, Canada., Kerr KM; Department of Pathology, Aberdeen University School of Medicine and Aberdeen Royal Infirmary, Aberdeen, Scotland., Lin D; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) and Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China., Minami Y; Department of Pathology, National Hospital Organization Ibarakihigashi National Hospital, The Center of Chest Diseases and Severe Motor & Intellectual Disabilities, Tokai, Ibaraki, Japan., Mino-Kenudson M; Department of Pathology, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts., Nicholson AG; Department of Histopathology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom., Papotti M; Department of Oncology, University of Turin, Torino, Italy., Rekhtman N; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Roden AC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., von der Thüsen JH; Department of Pathology, Erasmus MC, Rotterdam, The Netherlands., Travis W; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Tsao MS; Department of Pathology, University Health Network and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Yatabe Y; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Yeh YC; Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital and Department of Pathology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan., Bubendorf L; Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland., Chang WC; Department of Pathology, Taipei Medical University Hospital and Taipei Medical University, Taipei, Taiwan., Denninghoff V; Molecular-Clinical Laboratory, University of Buenos Aires-National Council for Scientific and Technical Research (CONICET), Buenos Aires, Argentina., Fernandes Tavora FR; Department of Pathology and Forensic Medicine, Faculty of Medicine, Federal University of Ceará, Fortaleza, Brazil., Hayashi T; Department of Human Pathology, Juntendo University Faculty of Medicine, Tokyo, Japan., Hofman P; Laboratory of Clinical and Experimental Pathology, Hôpital Pasteur, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, France., Jain D; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India., Kim TJ; Department of Hospital Pathology, Yeouido St. Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea., Lantuejoul S; Université de Grenoble Alpes, Grenoble and Department of Pathology, Centre Leon Berard, Lyon, France., Le Quesne J; Beatson Cancer Research Institute, University of Glasgow, NHS Greater Glasgow and Clyde Glasgow, Glasgow, United Kingdom., Lopez-Rios F; Pathology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Matsubara D; Department of Pathology, University of Tsukuba, Tsukuba, Ibaraki, Japan., Noguchi M; Department of Pathology, Narita Tomisato Tokushukai Hospital, Chiba, Japan., Radonic T; Department of Pathology, Amsterdam University Medical Center, Free University Amsterdam, Amsterdam, The Netherlands., Saqi A; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York., Schalper K; Department of Pathology and Medicine, Yale School of Medicine, New Haven, Connecticut., Shim HS; Department of Pathology, Yonsei University College of Medicine, Seoul, Republic of Korea., Sholl L; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Weissferdt A; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston., Cooper WA; Royal Prince Alfred Hospital, NSW Health Pathology, Camperdown, New South Wales, Australia.

Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2024 Nov 22. Date of Electronic Publication: 2024 Nov 22.

Tricuspid annular plane systolic excursion to pulmonary artery systolic pressure ratio in chronic thromboembolic pulmonary hypertension improves with balloon pulmonary angioplasty.

Autor: Yang JZ; Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine University of California San Diego La Jolla California USA., Poch DS; Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine University of California San Diego La Jolla California USA., Ang L; Department of Medicine, Division of Cardiovascular Medicine University of California San Diego La Jolla California USA., Mahmud E; Department of Medicine, Division of Cardiovascular Medicine University of California San Diego La Jolla California USA., Bautista MA; Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine University of California San Diego La Jolla California USA., Alotaibi M; Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine University of California San Diego La Jolla California USA., Fernandes TM; Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine University of California San Diego La Jolla California USA., Kerr KM; Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine University of California San Diego La Jolla California USA., Papamatheakis DG; Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine University of California San Diego La Jolla California USA., Kim NH; Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine University of California San Diego La Jolla California USA.

Publikováno v: Pulmonary circulation [Pulm Circ] 2024 Oct 05; Vol. 14 (4), pp. e12452. Date of Electronic Publication: 2024 Oct 05 (Print Publication: 2024).

ROS1 fusions in resected stage I-III adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape project.

Autor: Speel EM; Department of Pathology, GROW-School for Oncology and Reproduction, Maastricht University Medical Center, MUMC+ Maastricht, Netherlands & Department of Pathology, Erasmus Medical Center, Rotterdam, Netherlands., Dafni U; ETOP IBCSG Partners Foundation, ETOP Statistical Center, Frontier Science Foundation-Hellas & National and Kapodistrian University of Athens, Athens, Greece., Thunnissen E; Department of Pathology, Amsterdam University Medical Centre, location VUmc, Cancer Center Amsterdam, Amsterdam, Netherlands., Hendrik Rüschoff J; Department of Pathology, University Hospital Zürich, Zurich, Switzerland., O'Brien C; Department of Histopathology, St James's Hospital and Trinity College, Dublin, Ireland., Kowalski J; Pathomorphology Department, Medical University of Gdansk, Gdansk, Poland., Kerr KM; Department of Pathology, Aberdeen Royal Infirmary - NHS Grampian, Aberdeen, United Kingdom., Bubendorf L; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland., Sansano I; Department of Pathology, Vall d'Hebron University Hospital, Barcelona, Spain., Joseph L; Department of Pathology, Lung Cancer Group Manchester, Manchester, United Kingdom., Kriegsmann M; Department of Histopathology, University Hospital Heidelberg, Germany., Navarro A; Department of Pathology, Hospital General Universitario de Valencia, Valencia, Spain., Monkhorst K; Pathology Department, NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands., Bille Madsen L; Pathology, Aarhus University Hospital, Aarhus, Denmark., Hernandez Losa J; Department of Pathology, Vall d'Hebron University Hospital, Barcelona, Spain., Biernat W; Pathomorphology Department, Medical University of Gdansk, Gdansk, Poland., Stenzinger A; Department of Histopathology, University Hospital Heidelberg, Germany., Rüland A; Department of Pathology, GROW-School for Oncology and Reproduction, Maastricht University Medical Center, MUMC+ Maastricht, Netherlands & Department of Pathology, Erasmus Medical Center, Rotterdam, Netherlands., Hillen LM; Department of Pathology, GROW-School for Oncology and Reproduction, Maastricht University Medical Center, MUMC+ Maastricht, Netherlands & Department of Pathology, Erasmus Medical Center, Rotterdam, Netherlands., Marti N; Translational Research Coordination, ETOP IBCSG Partners Foundation, Bern, Switzerland., Molina-Vila MA; Laboratory of Oncology, Pangaea Oncology, Dexeus University Hospital, Barcelona, Spain., Dellaporta T; ETOP Statistical Center, Frontier Science Foundation-Hellas, Athens, Greece., Kammler R; Translational Research Coordination, ETOP IBCSG Partners Foundation, Bern, Switzerland., Peters S; Oncology Department, CHUV - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Stahel RA; President, ETOP IBCSG Partners Foundation, Bern, Switzerland. Electronic address: rolf.stahel@etop.ibcsg.org., Finn SP; Department of Histopathology, St James's Hospital and Trinity College, Dublin, Ireland., Radonic T; Department of Pathology, Amsterdam University Medical Centre, location VUmc, Cancer Center Amsterdam, Amsterdam, Netherlands.

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Aug; Vol. 194, pp. 107860. Date of Electronic Publication: 2024 Jun 26.

Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx.

Autor: Frankell AM; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Dietzen M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Al Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Lim EL; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Karasaki T; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Ward S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Advanced Sequencing Facility, The Francis Crick Institute, London, UK., Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Colliver E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Huebner A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Bunkum A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Hill MS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Grigoriadis K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Moore DA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK., Black JRM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Liu WK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Thol K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Naceur-Lombardelli C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Cook DE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Salgado R; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Wilson GA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Bailey C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Angelova M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Bentham R; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Abbosh C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Nicholson AG; Department of Histopathology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK., Le Quesne J; Cancer Research UK Beatson Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Pathology Department, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK., Biswas D; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK., Rosenthal R; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Puttick C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Hessey S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Lee C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Division of Medicine, University College London, London, UK., Prymas P; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Toncheva A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Smith J; Scientific Computing, The Francis Crick Institute, London, UK., Xing W; Scientific Computing, The Francis Crick Institute, London, UK., Nicod J; Advanced Sequencing Facility, The Francis Crick Institute, London, UK., Price G; Department of Medical Oncology, Aberdeen Royal Infirmary NHS Grampian, Aberdeen, UK.; University of Aberdeen, Aberdeen, UK., Kerr KM; University of Aberdeen, Aberdeen, UK.; Department of Pathology, Aberdeen Royal Infirmary NHS Grampian, Aberdeen, UK., Naidu B; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.; University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Middleton G; University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Blyth KG; Cancer Research UK Beatson Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Queen Elizabeth University Hospital, Glasgow, UK., Fennell DA; University of Leicester, Leicester, UK.; University Hospitals of Leicester NHS Trust, Leicester, UK., Forster MD; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK., Lee SM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK., Falzon M; Department of Cellular Pathology, University College London Hospitals, London, UK., Hewish M; Royal Surrey Hospital, Royal Surrey Hospitals NHS Foundation Trust, Guilford, UK.; University of Surrey, Guilford, UK., Shackcloth MJ; Liverpool Heart and Chest Hospital, Liverpool, UK., Lim E; Academic Division of Thoracic Surgery, Imperial College London, London, UK.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK., Benafif S; Department of Oncology, University College London Hospitals, London, UK., Russell P; Princess Alexandra Hospital, The Princess Alexandra Hospital NHS Trust, Harlow, UK., Boleti E; Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK., Krebs MG; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Lester JF; Singleton Hospital, Swansea Bay University Health Board, Swansea, UK., Papadatos-Pastos D; Department of Oncology, University College London Hospitals, London, UK., Ahmad T; Department of Oncology, University College London Hospitals, London, UK., Thakrar RM; Department of Thoracic Medicine, University College London Hospitals, London, UK.; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Lawrence D; Department of Thoracic Surgery, University College London Hospital NHS Trust, London, UK., Navani N; Department of Thoracic Medicine, University College London Hospitals, London, UK.; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Janes SM; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Dive C; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University of Manchester, Manchester, UK., Blackhall FH; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Summers Y; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Cave J; Department of Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Marafioti T; Department of Cellular Pathology, University College London Hospitals, London, UK., Herrero J; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK., Quezada SA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Immune Regulation and Tumour Immunotherapy Group, Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK., Peggs KS; Department of Haematology, University College London Hospitals, London, UK.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK., Schwarz RF; Institute for Computational Cancer Biology, Center for Integrated Oncology (CIO), Cancer Research Center Cologne Essen (CCCE), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Berlin Institute for the Foundations of Learning and Data (BIFOLD), Berlin, Germany., Van Loo P; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK., Miedema DM; LEXOR, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands., Birkbak NJ; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark., Hiley CT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Hackshaw A; Cancer Research UK and UCL Cancer Trials Centre, London, UK., Zaccaria S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. m.jamal-hanjani@ucl.ac.uk., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. charles.swanton@crick.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. charles.swanton@crick.ac.uk.

Publikováno v: Nature [Nature] 2024 Jul; Vol. 631 (8022), pp. E15.